Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms
Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer...
Saved in:
Published in | Cancer letters Vol. 398; pp. 24 - 36 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier B.V
10.07.2017
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial–mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer.
•The expression and distribution of Asporin in pancreatic cancer are confirmed.•Asporin promotes invasion and migration of pancreatic cancer by regulating the EMT.•Asporin exerts its biological roles through autocrine and paracrine manners.•Asporin may be a potential prognostic biomarker for pancreatic cancer. |
---|---|
AbstractList | Abstract Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial–mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer. Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial–mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer. •The expression and distribution of Asporin in pancreatic cancer are confirmed.•Asporin promotes invasion and migration of pancreatic cancer by regulating the EMT.•Asporin exerts its biological roles through autocrine and paracrine manners.•Asporin may be a potential prognostic biomarker for pancreatic cancer. Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial-mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with ourin vitroexperiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer. Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial-mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer.Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial-mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer. Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial-mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer. |
Author | Wu, Huanwen Zhang, Hui Liang, Zhiyong Wang, Lili Wang, Li Liu, Tonghua Lu, Junliang |
Author_xml | – sequence: 1 givenname: Lili surname: Wang fullname: Wang, Lili – sequence: 2 givenname: Huanwen surname: Wu fullname: Wu, Huanwen – sequence: 3 givenname: Li surname: Wang fullname: Wang, Li – sequence: 4 givenname: Hui surname: Zhang fullname: Zhang, Hui – sequence: 5 givenname: Junliang surname: Lu fullname: Lu, Junliang – sequence: 6 givenname: Zhiyong surname: Liang fullname: Liang, Zhiyong email: liangzhiyong1220@yahoo.com – sequence: 7 givenname: Tonghua surname: Liu fullname: Liu, Tonghua email: Tonghua_liu@163.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28400334$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkl9rFDEUxQep2D_6DUQCvtSHWW8myc6MiFBK_QMVH6zPIZO5s5s1k4xJprCfyS9pdrdFKEjxKVz4nXPDOfe0OHLeYVG8pLCgQJdvNwutnMW0qIDWC-ALAPqkOKFNXZV128BRcQIMeMkaJo6L0xg3ACB4LZ4Vx1XDARjjJ8Xvizj5YByZgh99wkgm5XRAlYwmeYHGQDRaS4y7VdF4R5TryWhWIRN56rYk4Gq2eXIrktZIcDL5sUbZMvlyxIhOr7ejsiQF5aLZy86vvt68yXjw82pNOp_WRM3J6_wT3G-YVFCHaUS9Vs7EMT4vng7KRnxx954VPz5e3Vx-Lq-_ffpyeXFdarHkqazZwGgHnHEFqhl6rllFB2xRAHZDJzQ0bdUAb7sBoRNKtA2rWaVV1VPOemRnxfnBN2fya8aY5GjiLgTl0M9R0qapQVAmqoy-foBu_Bxc_l2mWiEA-LLO1Ks7au5G7OUUzKjCVt7XkIF3B0AHH2PAQWqT9gHnzIyVFOSuc7mRh87lrnMJXObOs5g_EN_7PyL7cJBhjvLWYJBRm9wV9iagTrL35n8NtDXOaGV_4hbj3yBkrCTI77tr3B0jrRlUDJbZ4P2_DR7f_wc0UPQk |
CitedBy_id | crossref_primary_10_3892_mmr_2021_12459 crossref_primary_10_1007_s13300_018_0509_y crossref_primary_10_1016_j_heliyon_2020_e05632 crossref_primary_10_1002_jor_26039 crossref_primary_10_3390_genes14061251 crossref_primary_10_1016_j_matbio_2022_04_005 crossref_primary_10_1016_j_prp_2023_154462 crossref_primary_10_1111_pin_13211 crossref_primary_10_1096_fj_202100111R crossref_primary_10_3389_fonc_2021_646399 crossref_primary_10_1002_1878_0261_12399 crossref_primary_10_1016_j_bbcan_2023_189029 crossref_primary_10_1016_j_bbcan_2024_189225 crossref_primary_10_3390_ijms242115906 crossref_primary_10_1038_s41419_018_0444_x crossref_primary_10_1016_j_bbcan_2020_188418 crossref_primary_10_1159_000515458 crossref_primary_10_3389_fphys_2020_00174 crossref_primary_10_1016_j_stem_2025_02_009 crossref_primary_10_1038_s41388_021_01858_7 crossref_primary_10_1177_10104283241313441 crossref_primary_10_1016_j_canlet_2022_216040 crossref_primary_10_1038_s41417_019_0146_2 crossref_primary_10_3892_etm_2018_6302 crossref_primary_10_1038_s41388_021_02140_6 crossref_primary_10_1111_cas_14794 crossref_primary_10_3389_fimmu_2024_1287459 crossref_primary_10_3389_fmolb_2022_833079 crossref_primary_10_3389_fonc_2019_00948 crossref_primary_10_1016_j_diff_2025_100860 crossref_primary_10_1016_j_gene_2023_147573 crossref_primary_10_1165_rcmb_2021_0257OC crossref_primary_10_3892_ijo_2022_5406 crossref_primary_10_1002_1878_0261_13077 crossref_primary_10_1016_j_neulet_2024_137832 crossref_primary_10_3390_pharmaceutics14050988 crossref_primary_10_1016_j_prp_2020_153313 crossref_primary_10_1371_journal_pone_0255915 crossref_primary_10_1002_cjp2_205 crossref_primary_10_1002_cam4_1752 crossref_primary_10_1016_j_canlet_2019_07_015 crossref_primary_10_1248_cpb_c17_00582 crossref_primary_10_1016_j_bbrc_2019_05_167 crossref_primary_10_2174_1871520619666190730103425 crossref_primary_10_3389_fcell_2021_783617 crossref_primary_10_1186_s12885_019_6301_1 crossref_primary_10_3390_cancers12051347 crossref_primary_10_1007_s13224_023_01749_9 crossref_primary_10_1016_j_semcancer_2019_08_026 crossref_primary_10_14814_phy2_13907 crossref_primary_10_3390_cancers14215328 crossref_primary_10_4014_jmb_2110_10032 crossref_primary_10_1038_s41419_019_1376_9 crossref_primary_10_1158_0008_5472_CAN_18_2931 crossref_primary_10_1016_j_molmed_2023_03_002 crossref_primary_10_1016_j_dld_2019_09_013 crossref_primary_10_1016_j_omtn_2021_10_017 crossref_primary_10_3389_fbioe_2022_1025546 crossref_primary_10_3892_mmr_2018_8950 crossref_primary_10_1002_ctm2_670 crossref_primary_10_1042_BSR20181501 crossref_primary_10_1186_s12943_020_01300_8 crossref_primary_10_1186_s12917_024_04275_6 crossref_primary_10_1097_MD_0000000000032490 |
Cites_doi | 10.4161/cbt.8.16.8961 10.1016/j.ccr.2013.01.023 10.3322/caac.21254 10.1101/gad.1228704 10.1074/jbc.M700522200 10.1158/1541-7786.MCR-12-0307 10.1016/j.canlet.2013.12.006 10.1016/j.cell.2011.11.025 10.1158/0008-5472.CAN-07-2477 10.1038/sj.onc.1209934 10.1038/nrc3023 10.1242/jcs.099697 10.1021/pr200527z 10.1007/s10495-012-0715-4 10.3109/17435390.2014.980760 10.1016/S0016-5085(98)70209-4 10.1186/1478-811X-9-18 10.18632/oncotarget.10471 10.1158/0008-5472.CAN-05-0779 10.1016/j.canlet.2010.03.003 10.1158/0008-5472.CAN-07-5714 10.1158/0008-5472.CAN-08-1132 10.3322/caac.21208 10.1046/j.1432-0436.2002.700904.x 10.1158/1078-0432.CCR-15-0256 10.1038/nature12626 10.1016/j.cell.2013.06.005 10.1097/00006676-200311000-00008 10.18632/oncotarget.3099 10.1038/35077241 10.1371/journal.pmed.1001871 10.18632/oncotarget.2398 10.1016/S0378-1119(01)00683-7 10.1038/onc.2013.584 10.1038/ncomms10715 10.1186/1476-4598-8-125 10.1002/ijc.11081 10.1074/jbc.M501625200 10.1042/BSR20130102 10.3389/fphys.2014.00088 |
ContentType | Journal Article |
Copyright | 2017 Elsevier B.V. Elsevier B.V. Copyright © 2017 Elsevier B.V. All rights reserved. Copyright Elsevier Limited Jul 10, 2017 |
Copyright_xml | – notice: 2017 Elsevier B.V. – notice: Elsevier B.V. – notice: Copyright © 2017 Elsevier B.V. All rights reserved. – notice: Copyright Elsevier Limited Jul 10, 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO 7U9 H94 K9. NAPCQ 7X8 |
DOI | 10.1016/j.canlet.2017.04.001 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1872-7980 |
EndPage | 36 |
ExternalDocumentID | 28400334 10_1016_j_canlet_2017_04_001 S0304383517302306 1_s2_0_S0304383517302306 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29B 4.4 457 4CK 4G. 5GY 5RE 5VS 6J9 6PF 7-5 71M 8FE 8FH 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABGSF ABJNI ABMAC ABMZM ABUDA ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACVFH ADBBV ADCNI ADEZE ADFRT ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IH2 IHE J1W K-O KOM LK8 M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 ROL RPZ SCC SDF SDG SDP SEL SES SPCBC SSH SSU SSZ T5K Z5R ~G- .55 .GJ 3O- 3V. 53G 7RV 7X7 8C1 8FI AACTN AAQXK ABWVN ABXDB ACRPL ADMUD ADNMO AFCTW AFFNX AFJKZ AFKRA AFKWA AGRDE AI. AJOXV AMFUW ASPBG AVWKF AZFZN AZQEC BBNVY BENPR BHPHI FEDTE FGOYB FYUFA G-2 GUQSH HCIFZ HED HMK HMO HVGLF HZ~ M1P M2M M2O M7P R2- RIG SAE SEW UDS VH1 WUQ X7M ZGI AAIAV ABLVK ABYKQ AJBFU DOVZS EFLBG LCYCR AAYXX AGQPQ AGRNS AIGII CITATION CGR CUY CVF ECM EIF NPM 7TO 7U9 H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c564t-73f31b0434a0a8fd4c321fe9e50ebfb5c08928049bfe0b5a5983732ca2d143de3 |
IEDL.DBID | .~1 |
ISSN | 0304-3835 1872-7980 |
IngestDate | Fri Jul 11 05:34:20 EDT 2025 Wed Aug 13 06:10:26 EDT 2025 Wed Feb 19 02:42:08 EST 2025 Tue Jul 01 02:29:34 EDT 2025 Thu Apr 24 23:09:00 EDT 2025 Fri Feb 23 02:33:50 EST 2024 Tue Feb 25 20:11:25 EST 2025 Tue Aug 26 17:11:47 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Migration MMPs CM TMAs EMT Invasion ECM PCC ASC SLRP α-SMA PDAC CAFs Asporin Pancreatic cancer PSCs ATRA conditioned medium α-smooth muscle actin pancreatic ductal adenocarcinoma Tissue microarrays matrix metalloproteinases pancreatic stellate cells all-trans retinoic acid pancreatic cancer cell cancer-associated fibroblasts the American Cancer Society small leucine-rich proteoglycan extracellular matrix |
Language | English |
License | Copyright © 2017 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c564t-73f31b0434a0a8fd4c321fe9e50ebfb5c08928049bfe0b5a5983732ca2d143de3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 28400334 |
PQID | 1895500467 |
PQPubID | 2031080 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_1887051352 proquest_journals_1895500467 pubmed_primary_28400334 crossref_citationtrail_10_1016_j_canlet_2017_04_001 crossref_primary_10_1016_j_canlet_2017_04_001 elsevier_sciencedirect_doi_10_1016_j_canlet_2017_04_001 elsevier_clinicalkeyesjournals_1_s2_0_S0304383517302306 elsevier_clinicalkey_doi_10_1016_j_canlet_2017_04_001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-07-10 |
PublicationDateYYYYMMDD | 2017-07-10 |
PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-10 day: 10 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland – name: Clare |
PublicationTitle | Cancer letters |
PublicationTitleAlternate | Cancer Lett |
PublicationYear | 2017 |
Publisher | Elsevier B.V Elsevier Limited |
Publisher_xml | – name: Elsevier B.V – name: Elsevier Limited |
References | Hurley, Sundi, Shinder, Simons, Hughes, Miller (bib10) 2016; 22 Satoyoshi, Kuriyama, Aiba, Yashiro, Tanaka (bib13) 2015; 34 Asano, Yao, Shin, McCubrey, Abbruzzese, Reddy (bib43) 2005; 65 Apte, Wilson (bib5) 2003; 27 Tyagi, Bhardwaj, Singh, McClellan, Carter, Singh (bib40) 2014; 5 Gos, Miloszewska, Przybyszewska (bib30) 2009; 55 Chaffer, Marjanovic, Lee, Bell, Kleer, Reinhardt (bib28) 2013; 154 Siegel, Ma, Zou, Jemal (bib3) 2014; 64 Junttila, de Sauvage (bib23) 2013; 501 Simkova, Kharaishvili, Korinkova, Ozdian, Suchankova-Kleplova, Soukup (bib27) 2016 Zoller (bib14) 2011; 11 Turtoi, Musmeci, Wang, Dumont, Somja, Bevilacqua (bib11) 2011; 10 Fidler (bib22) 2002; 70 Zhang, Wu, Guan, Wang, Ren, Shi (bib15) 2015; 6 Wu, Jing, Cheng, He, Hu, Wu (bib26) 2016 Gumireddy, Li, Kossenkov, Sakurai, Yan, Li (bib39) 2016; 7 Guan, Zhang, Wen, Gu, Cheng, Sun (bib16) 2014; 345 Shimobayashi, Hall (bib41) 2014; 15 Li, Zhang, Zheng, Guo (bib46) 2015; 8 Vonlaufen, Joshi, Qu, Phillips, Xu, Parker (bib7) 2008; 68 Fu, Feng, Zeng, Ding, Yu, Yang (bib38) 2014 Yang, Huang (bib19) 2005; 280 Chung, Vadgama (bib45) 2015; 35 Liptay, Weber, Ludwig, Wagner, Adler, Schmid (bib32) 2003; 105 Wharry, Haines, Carroll, May (bib33) 2009; 8 Kar, Palit, Ball, Das (bib37) 2012; 17 Hwang, Moore, Arumugam, Ramachandran, Amos, Rivera (bib4) 2008; 68 Liotta, Kohn (bib21) 2001; 411 Hayden, Ghosh (bib35) 2004; 18 Eser, Reiff, Messer, Seidler, Gottschalk, Dobler (bib42) 2013; 23 Nakajima, Kizawa, Saitoh, Kou, Miyazono, Ikegawa (bib9) 2007; 282 Huanwen, Zhiyong, Xiaohua, Xinyu, Kai, Tonghua (bib17) 2009; 8 Rhim, Mirek, Aiello, Maitra, Bailey, McAllister (bib29) 2012; 148 Albini, Iwamoto, Kleinman, Martin, Aaronson, Kozlowski (bib20) 1987; 47 Maris, Blomme, Palacios, Costanza, Bellahcene, Bianchi (bib12) 2015; 12 Bachem, Schneider, Gross, Weidenbach, Schmid, Menke (bib18) 1998; 115 Ungefroren, Sebens, Seidl, Lehnert, Hass (bib24) 2011; 9 Scheidereit (bib36) 2006; 25 Maier, Schmidt-Strassburger, Huber, Wiedemann, Beug, Wirth (bib34) 2010; 295 Tan, Yaffee, Jamil, Lo, Nissen, Pandol (bib1) 2014; 5 Karagiannis, Poutahidis, Erdman, Kirsch, Riddell, Diamandis (bib25) 2012; 10 Vonlaufen, Phillips, Xu, Goldstein, Pirola, Wilson (bib6) 2008; 68 Bohmert, Niemann, Lichtenstein, Juling, Lampen (bib44) 2015; 9 Siegel, Miller, Jemal (bib2) 2015; 65 Huang, Guilford, Thiery (bib31) 2012; 125 Yamada, Murakami, Matoba, Ozawa, Yokokoji, Nakahira (bib8) 2001; 275 Zoller (10.1016/j.canlet.2017.04.001_bib14) 2011; 11 Rhim (10.1016/j.canlet.2017.04.001_bib29) 2012; 148 Siegel (10.1016/j.canlet.2017.04.001_bib3) 2014; 64 Bohmert (10.1016/j.canlet.2017.04.001_bib44) 2015; 9 Yang (10.1016/j.canlet.2017.04.001_bib19) 2005; 280 Scheidereit (10.1016/j.canlet.2017.04.001_bib36) 2006; 25 Fidler (10.1016/j.canlet.2017.04.001_bib22) 2002; 70 Gos (10.1016/j.canlet.2017.04.001_bib30) 2009; 55 Nakajima (10.1016/j.canlet.2017.04.001_bib9) 2007; 282 Maris (10.1016/j.canlet.2017.04.001_bib12) 2015; 12 Maier (10.1016/j.canlet.2017.04.001_bib34) 2010; 295 Junttila (10.1016/j.canlet.2017.04.001_bib23) 2013; 501 Hwang (10.1016/j.canlet.2017.04.001_bib4) 2008; 68 Vonlaufen (10.1016/j.canlet.2017.04.001_bib6) 2008; 68 Zhang (10.1016/j.canlet.2017.04.001_bib15) 2015; 6 Chaffer (10.1016/j.canlet.2017.04.001_bib28) 2013; 154 Hurley (10.1016/j.canlet.2017.04.001_bib10) 2016; 22 Simkova (10.1016/j.canlet.2017.04.001_bib27) 2016 Huanwen (10.1016/j.canlet.2017.04.001_bib17) 2009; 8 Wharry (10.1016/j.canlet.2017.04.001_bib33) 2009; 8 Siegel (10.1016/j.canlet.2017.04.001_bib2) 2015; 65 Yamada (10.1016/j.canlet.2017.04.001_bib8) 2001; 275 Bachem (10.1016/j.canlet.2017.04.001_bib18) 1998; 115 Albini (10.1016/j.canlet.2017.04.001_bib20) 1987; 47 Satoyoshi (10.1016/j.canlet.2017.04.001_bib13) 2015; 34 Wu (10.1016/j.canlet.2017.04.001_bib26) 2016 Eser (10.1016/j.canlet.2017.04.001_bib42) 2013; 23 Huang (10.1016/j.canlet.2017.04.001_bib31) 2012; 125 Hayden (10.1016/j.canlet.2017.04.001_bib35) 2004; 18 Shimobayashi (10.1016/j.canlet.2017.04.001_bib41) 2014; 15 Li (10.1016/j.canlet.2017.04.001_bib46) 2015; 8 Tyagi (10.1016/j.canlet.2017.04.001_bib40) 2014; 5 Kar (10.1016/j.canlet.2017.04.001_bib37) 2012; 17 Turtoi (10.1016/j.canlet.2017.04.001_bib11) 2011; 10 Karagiannis (10.1016/j.canlet.2017.04.001_bib25) 2012; 10 Asano (10.1016/j.canlet.2017.04.001_bib43) 2005; 65 Ungefroren (10.1016/j.canlet.2017.04.001_bib24) 2011; 9 Fu (10.1016/j.canlet.2017.04.001_bib38) 2014 Tan (10.1016/j.canlet.2017.04.001_bib1) 2014; 5 Liotta (10.1016/j.canlet.2017.04.001_bib21) 2001; 411 Liptay (10.1016/j.canlet.2017.04.001_bib32) 2003; 105 Gumireddy (10.1016/j.canlet.2017.04.001_bib39) 2016; 7 Apte (10.1016/j.canlet.2017.04.001_bib5) 2003; 27 Vonlaufen (10.1016/j.canlet.2017.04.001_bib7) 2008; 68 Guan (10.1016/j.canlet.2017.04.001_bib16) 2014; 345 Chung (10.1016/j.canlet.2017.04.001_bib45) 2015; 35 |
References_xml | – volume: 65 start-page: 5 year: 2015 end-page: 29 ident: bib2 article-title: Cancer statistics, 2015 publication-title: CA Cancer J. Clin. – volume: 9 start-page: 18 year: 2011 ident: bib24 article-title: Interaction of tumor cells with the microenvironment publication-title: Cell Commun. Signal. CCS – volume: 125 start-page: 4417 year: 2012 end-page: 4422 ident: bib31 article-title: Early events in cell adhesion and polarity during epithelial-mesenchymal transition publication-title: J. Cell Sci. – volume: 5 start-page: 8778 year: 2014 end-page: 8789 ident: bib40 article-title: p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-kappaB pathway publication-title: Oncotarget – volume: 295 start-page: 214 year: 2010 end-page: 228 ident: bib34 article-title: NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells publication-title: Cancer Lett. – volume: 5 start-page: 88 year: 2014 ident: bib1 article-title: Pancreatic cancer cachexia: a review of mechanisms and therapeutics publication-title: Front. Physiol. – volume: 282 start-page: 32185 year: 2007 end-page: 32192 ident: bib9 article-title: Mechanisms for asporin function and regulation in articular cartilage publication-title: J. Biol. Chem. – volume: 275 start-page: 279 year: 2001 end-page: 286 ident: bib8 article-title: Expression profile of active genes in human periodontal ligament and isolation of PLAP-1, a novel SLRP family gene publication-title: Gene – volume: 34 start-page: 650 year: 2015 end-page: 660 ident: bib13 article-title: Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts publication-title: Oncogene – volume: 8 start-page: 6724 year: 2015 end-page: 6731 ident: bib46 article-title: Expression of CD44 in pancreatic cancer and its significance publication-title: Int. J. Clin. Exp. Pathol. – volume: 8 start-page: 125 year: 2009 ident: bib17 article-title: Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines publication-title: Mol. Cancer – volume: 7 start-page: 10715 year: 2016 ident: bib39 article-title: The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis publication-title: Nat. Commun. – volume: 65 start-page: 9164 year: 2005 end-page: 9168 ident: bib43 article-title: Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells publication-title: Cancer Res. – volume: 22 start-page: 448 year: 2016 end-page: 458 ident: bib10 article-title: Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer publication-title: Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. – year: 2016 ident: bib26 article-title: Asporin enhances colorectal cancer metastasis through activating the EGFR/src/cortactin signaling pathway publication-title: Oncotarget – volume: 64 start-page: 9 year: 2014 end-page: 29 ident: bib3 article-title: Cancer statistics, 2014 publication-title: CA Cancer J. Clin. – volume: 55 start-page: 121 year: 2009 end-page: 128 ident: bib30 article-title: Epithelial-mesenchymal transition in cancer progression publication-title: Postep. Biochem. – volume: 68 start-page: 2085 year: 2008 end-page: 2093 ident: bib7 article-title: Pancreatic stellate cells: partners in crime with pancreatic cancer cells publication-title: Cancer Res. – volume: 11 start-page: 254 year: 2011 end-page: 267 ident: bib14 article-title: CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? publication-title: Nat. Rev. Cancer – volume: 27 start-page: 316 year: 2003 end-page: 320 ident: bib5 article-title: Stellate cell activation in alcoholic pancreatitis publication-title: Pancreas – volume: 68 start-page: 918 year: 2008 end-page: 926 ident: bib4 article-title: Cancer-associated stromal fibroblasts promote pancreatic tumor progression publication-title: Cancer Res. – volume: 12 start-page: e1001871 year: 2015 ident: bib12 article-title: Asporin is a fibroblast-derived TGF-beta1 inhibitor and a tumor suppressor associated with good prognosis in breast cancer publication-title: PLoS Med. – volume: 8 start-page: 1567 year: 2009 end-page: 1576 ident: bib33 article-title: Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells publication-title: Cancer Biol. Ther. – volume: 15 start-page: 155 year: 2014 end-page: 162 ident: bib41 article-title: Making new contacts: the mTOR network in metabolism and signalling crosstalk, Nature reviews publication-title: Mol. Cell Biol. – volume: 68 start-page: 7707 year: 2008 end-page: 7710 ident: bib6 article-title: Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance publication-title: Cancer Res. – volume: 280 start-page: 27130 year: 2005 end-page: 27137 ident: bib19 article-title: Ca2+ influx through L-type Ca2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration publication-title: J. Biol. Chem. – volume: 10 start-page: 1403 year: 2012 end-page: 1418 ident: bib25 article-title: Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue publication-title: Mol. Cancer Res. MCR – volume: 115 start-page: 421 year: 1998 end-page: 432 ident: bib18 article-title: Identification, culture, and characterization of pancreatic stellate cells in rats and humans publication-title: Gastroenterology – volume: 345 start-page: 132 year: 2014 end-page: 139 ident: bib16 article-title: Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells publication-title: Cancer Lett. – volume: 105 start-page: 735 year: 2003 end-page: 746 ident: bib32 article-title: Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer publication-title: Int. J. Cancer – volume: 25 start-page: 6685 year: 2006 end-page: 6705 ident: bib36 article-title: IkappaB kinase complexes: gateways to NF-kappaB activation and transcription publication-title: Oncogene – volume: 9 start-page: 852 year: 2015 end-page: 860 ident: bib44 article-title: Molecular mechanism of silver nanoparticles in human intestinal cells publication-title: Nanotoxicology – volume: 35 start-page: 39 year: 2015 end-page: 46 ident: bib45 article-title: Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFkappaB signaling publication-title: Anticancer Res. – volume: 47 start-page: 3239 year: 1987 end-page: 3245 ident: bib20 article-title: A rapid in vitro assay for quantitating the invasive potential of tumor cells publication-title: Cancer Res. – volume: 501 start-page: 346 year: 2013 end-page: 354 ident: bib23 article-title: Influence of tumour micro-environment heterogeneity on therapeutic response publication-title: Nature – volume: 148 start-page: 349 year: 2012 end-page: 361 ident: bib29 article-title: EMT and dissemination precede pancreatic tumor formation publication-title: Cell – year: 2016 ident: bib27 article-title: The dual role of asporin in breast cancer progression publication-title: Oncotarget – volume: 18 start-page: 2195 year: 2004 end-page: 2224 ident: bib35 article-title: Signaling to NF-kappaB publication-title: Genes Dev. – volume: 17 start-page: 735 year: 2012 end-page: 747 ident: bib37 article-title: Carnosic acid modulates Akt/IKK/NF-kappaB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells publication-title: Apoptosis Int. J. Program. Cell Death – volume: 23 start-page: 406 year: 2013 end-page: 420 ident: bib42 article-title: Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer publication-title: Cancer Cell – volume: 411 start-page: 375 year: 2001 end-page: 379 ident: bib21 article-title: The microenvironment of the tumour-host interface publication-title: Nature – volume: 6 start-page: 3085 year: 2015 end-page: 3097 ident: bib15 article-title: Paracrine SDF-1alpha signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells publication-title: Oncotarget – volume: 70 start-page: 498 year: 2002 end-page: 505 ident: bib22 article-title: The organ microenvironment and cancer metastasis publication-title: Differ. Res. Biol. Divers. – volume: 154 start-page: 61 year: 2013 end-page: 74 ident: bib28 article-title: Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity publication-title: Cell – volume: 10 start-page: 4302 year: 2011 end-page: 4313 ident: bib11 article-title: Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma publication-title: J. Proteome Res. – year: 2014 ident: bib38 article-title: PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/Erk-dependent pathways publication-title: Biosci. Rep. – volume: 8 start-page: 1567 year: 2009 ident: 10.1016/j.canlet.2017.04.001_bib33 article-title: Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.8.16.8961 – volume: 15 start-page: 155 year: 2014 ident: 10.1016/j.canlet.2017.04.001_bib41 article-title: Making new contacts: the mTOR network in metabolism and signalling crosstalk, Nature reviews publication-title: Mol. Cell Biol. – volume: 23 start-page: 406 year: 2013 ident: 10.1016/j.canlet.2017.04.001_bib42 article-title: Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.01.023 – volume: 65 start-page: 5 year: 2015 ident: 10.1016/j.canlet.2017.04.001_bib2 article-title: Cancer statistics, 2015 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21254 – volume: 18 start-page: 2195 year: 2004 ident: 10.1016/j.canlet.2017.04.001_bib35 article-title: Signaling to NF-kappaB publication-title: Genes Dev. doi: 10.1101/gad.1228704 – volume: 55 start-page: 121 year: 2009 ident: 10.1016/j.canlet.2017.04.001_bib30 article-title: Epithelial-mesenchymal transition in cancer progression publication-title: Postep. Biochem. – volume: 282 start-page: 32185 year: 2007 ident: 10.1016/j.canlet.2017.04.001_bib9 article-title: Mechanisms for asporin function and regulation in articular cartilage publication-title: J. Biol. Chem. doi: 10.1074/jbc.M700522200 – volume: 10 start-page: 1403 year: 2012 ident: 10.1016/j.canlet.2017.04.001_bib25 article-title: Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue publication-title: Mol. Cancer Res. MCR doi: 10.1158/1541-7786.MCR-12-0307 – volume: 345 start-page: 132 year: 2014 ident: 10.1016/j.canlet.2017.04.001_bib16 article-title: Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells publication-title: Cancer Lett. doi: 10.1016/j.canlet.2013.12.006 – volume: 148 start-page: 349 year: 2012 ident: 10.1016/j.canlet.2017.04.001_bib29 article-title: EMT and dissemination precede pancreatic tumor formation publication-title: Cell doi: 10.1016/j.cell.2011.11.025 – volume: 68 start-page: 2085 year: 2008 ident: 10.1016/j.canlet.2017.04.001_bib7 article-title: Pancreatic stellate cells: partners in crime with pancreatic cancer cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-2477 – volume: 25 start-page: 6685 year: 2006 ident: 10.1016/j.canlet.2017.04.001_bib36 article-title: IkappaB kinase complexes: gateways to NF-kappaB activation and transcription publication-title: Oncogene doi: 10.1038/sj.onc.1209934 – volume: 11 start-page: 254 year: 2011 ident: 10.1016/j.canlet.2017.04.001_bib14 article-title: CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3023 – volume: 125 start-page: 4417 year: 2012 ident: 10.1016/j.canlet.2017.04.001_bib31 article-title: Early events in cell adhesion and polarity during epithelial-mesenchymal transition publication-title: J. Cell Sci. doi: 10.1242/jcs.099697 – volume: 10 start-page: 4302 year: 2011 ident: 10.1016/j.canlet.2017.04.001_bib11 article-title: Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma publication-title: J. Proteome Res. doi: 10.1021/pr200527z – volume: 35 start-page: 39 year: 2015 ident: 10.1016/j.canlet.2017.04.001_bib45 article-title: Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFkappaB signaling publication-title: Anticancer Res. – volume: 17 start-page: 735 year: 2012 ident: 10.1016/j.canlet.2017.04.001_bib37 article-title: Carnosic acid modulates Akt/IKK/NF-kappaB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells publication-title: Apoptosis Int. J. Program. Cell Death doi: 10.1007/s10495-012-0715-4 – volume: 9 start-page: 852 year: 2015 ident: 10.1016/j.canlet.2017.04.001_bib44 article-title: Molecular mechanism of silver nanoparticles in human intestinal cells publication-title: Nanotoxicology doi: 10.3109/17435390.2014.980760 – volume: 8 start-page: 6724 year: 2015 ident: 10.1016/j.canlet.2017.04.001_bib46 article-title: Expression of CD44 in pancreatic cancer and its significance publication-title: Int. J. Clin. Exp. Pathol. – volume: 115 start-page: 421 year: 1998 ident: 10.1016/j.canlet.2017.04.001_bib18 article-title: Identification, culture, and characterization of pancreatic stellate cells in rats and humans publication-title: Gastroenterology doi: 10.1016/S0016-5085(98)70209-4 – volume: 9 start-page: 18 year: 2011 ident: 10.1016/j.canlet.2017.04.001_bib24 article-title: Interaction of tumor cells with the microenvironment publication-title: Cell Commun. Signal. CCS doi: 10.1186/1478-811X-9-18 – year: 2016 ident: 10.1016/j.canlet.2017.04.001_bib27 article-title: The dual role of asporin in breast cancer progression publication-title: Oncotarget doi: 10.18632/oncotarget.10471 – volume: 65 start-page: 9164 year: 2005 ident: 10.1016/j.canlet.2017.04.001_bib43 article-title: Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-0779 – volume: 47 start-page: 3239 year: 1987 ident: 10.1016/j.canlet.2017.04.001_bib20 article-title: A rapid in vitro assay for quantitating the invasive potential of tumor cells publication-title: Cancer Res. – volume: 295 start-page: 214 year: 2010 ident: 10.1016/j.canlet.2017.04.001_bib34 article-title: NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells publication-title: Cancer Lett. doi: 10.1016/j.canlet.2010.03.003 – volume: 68 start-page: 918 year: 2008 ident: 10.1016/j.canlet.2017.04.001_bib4 article-title: Cancer-associated stromal fibroblasts promote pancreatic tumor progression publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-5714 – volume: 68 start-page: 7707 year: 2008 ident: 10.1016/j.canlet.2017.04.001_bib6 article-title: Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-1132 – volume: 64 start-page: 9 year: 2014 ident: 10.1016/j.canlet.2017.04.001_bib3 article-title: Cancer statistics, 2014 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21208 – volume: 70 start-page: 498 year: 2002 ident: 10.1016/j.canlet.2017.04.001_bib22 article-title: The organ microenvironment and cancer metastasis publication-title: Differ. Res. Biol. Divers. doi: 10.1046/j.1432-0436.2002.700904.x – volume: 22 start-page: 448 year: 2016 ident: 10.1016/j.canlet.2017.04.001_bib10 article-title: Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer publication-title: Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. doi: 10.1158/1078-0432.CCR-15-0256 – volume: 501 start-page: 346 year: 2013 ident: 10.1016/j.canlet.2017.04.001_bib23 article-title: Influence of tumour micro-environment heterogeneity on therapeutic response publication-title: Nature doi: 10.1038/nature12626 – volume: 154 start-page: 61 year: 2013 ident: 10.1016/j.canlet.2017.04.001_bib28 article-title: Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity publication-title: Cell doi: 10.1016/j.cell.2013.06.005 – volume: 27 start-page: 316 year: 2003 ident: 10.1016/j.canlet.2017.04.001_bib5 article-title: Stellate cell activation in alcoholic pancreatitis publication-title: Pancreas doi: 10.1097/00006676-200311000-00008 – volume: 6 start-page: 3085 year: 2015 ident: 10.1016/j.canlet.2017.04.001_bib15 article-title: Paracrine SDF-1alpha signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells publication-title: Oncotarget doi: 10.18632/oncotarget.3099 – volume: 411 start-page: 375 year: 2001 ident: 10.1016/j.canlet.2017.04.001_bib21 article-title: The microenvironment of the tumour-host interface publication-title: Nature doi: 10.1038/35077241 – volume: 12 start-page: e1001871 year: 2015 ident: 10.1016/j.canlet.2017.04.001_bib12 article-title: Asporin is a fibroblast-derived TGF-beta1 inhibitor and a tumor suppressor associated with good prognosis in breast cancer publication-title: PLoS Med. doi: 10.1371/journal.pmed.1001871 – volume: 5 start-page: 8778 year: 2014 ident: 10.1016/j.canlet.2017.04.001_bib40 article-title: p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-kappaB pathway publication-title: Oncotarget doi: 10.18632/oncotarget.2398 – volume: 275 start-page: 279 year: 2001 ident: 10.1016/j.canlet.2017.04.001_bib8 article-title: Expression profile of active genes in human periodontal ligament and isolation of PLAP-1, a novel SLRP family gene publication-title: Gene doi: 10.1016/S0378-1119(01)00683-7 – volume: 34 start-page: 650 year: 2015 ident: 10.1016/j.canlet.2017.04.001_bib13 article-title: Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts publication-title: Oncogene doi: 10.1038/onc.2013.584 – volume: 7 start-page: 10715 year: 2016 ident: 10.1016/j.canlet.2017.04.001_bib39 article-title: The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis publication-title: Nat. Commun. doi: 10.1038/ncomms10715 – volume: 8 start-page: 125 year: 2009 ident: 10.1016/j.canlet.2017.04.001_bib17 article-title: Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines publication-title: Mol. Cancer doi: 10.1186/1476-4598-8-125 – volume: 105 start-page: 735 year: 2003 ident: 10.1016/j.canlet.2017.04.001_bib32 article-title: Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer publication-title: Int. J. Cancer doi: 10.1002/ijc.11081 – volume: 280 start-page: 27130 year: 2005 ident: 10.1016/j.canlet.2017.04.001_bib19 article-title: Ca2+ influx through L-type Ca2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration publication-title: J. Biol. Chem. doi: 10.1074/jbc.M501625200 – year: 2014 ident: 10.1016/j.canlet.2017.04.001_bib38 article-title: PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/Erk-dependent pathways publication-title: Biosci. Rep. doi: 10.1042/BSR20130102 – volume: 5 start-page: 88 year: 2014 ident: 10.1016/j.canlet.2017.04.001_bib1 article-title: Pancreatic cancer cachexia: a review of mechanisms and therapeutics publication-title: Front. Physiol. doi: 10.3389/fphys.2014.00088 – year: 2016 ident: 10.1016/j.canlet.2017.04.001_bib26 article-title: Asporin enhances colorectal cancer metastasis through activating the EGFR/src/cortactin signaling pathway publication-title: Oncotarget |
SSID | ssj0005475 |
Score | 2.501383 |
Snippet | Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix... Abstract Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 24 |
SubjectTerms | Aged AKT protein Asporin Autocrine Communication Autocrine signalling Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Biotechnology Breast cancer CD44 antigen Cell Line, Tumor Cell Proliferation EMT Epithelial-Mesenchymal Transition Extracellular matrix Extracellular Matrix Proteins - genetics Extracellular Matrix Proteins - metabolism Extracellular Signal-Regulated MAP Kinases - metabolism Female Fibroblasts Gene expression Hematology, Oncology and Palliative Medicine Humans Hyaluronan Receptors - metabolism Invasion Kinases Male Mesenchyme Metabolic pathways Metastasis Middle Aged Migration Neoplasm Invasiveness Pancreatic cancer Pancreatic Neoplasms - genetics Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology Pancreatic Stellate Cells - metabolism Pancreatic Stellate Cells - pathology Paracrine Communication Paracrine signalling Penicillin Phosphorylation Proteins Proto-Oncogene Proteins c-akt - metabolism RNA Interference Signal Transduction Stellate cells Stroma Stromal Cells - metabolism Stromal Cells - pathology Transcription Factor RelA - metabolism Transfection Tumor Microenvironment |
Title | Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0304383517302306 https://www.clinicalkey.es/playcontent/1-s2.0-S0304383517302306 https://dx.doi.org/10.1016/j.canlet.2017.04.001 https://www.ncbi.nlm.nih.gov/pubmed/28400334 https://www.proquest.com/docview/1895500467 https://www.proquest.com/docview/1887051352 |
Volume | 398 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIiEuiDdLS2UkDnAw68T2JntcVa0W0PZCK_Vm2Y4DqZrsapOt1At_iD_JjOMsRRQVcXRiy5ZnPPONPQ9C3kqVFEbkE1YmXDApfYbvuylDqOBNaW0eklUvTibzM_npXJ3vkMMhFgbdKqPs72V6kNbxyzju5nhVVeMv-KgH9pVKMhGANEawywy5_MP3G24eMiTbxc4Mew_hc8HHC1YPu4MOXllIeBpLw9yinv4GP4MaOn5EHkb8SGf9Eh-THd88IfcX8YX8KfkxQzu1augq-Nn5lsJx75Ghow5JvKZ4WU-r5srgTRk1TUHr6mvPCdRe03Vfnh50GgV0SP0KwzYugU9Zt2Q1Riu5b9c1LKJDPRdcvui7o8XpexqL_lAL5Kdm0y0dxhaGGTDFeN-qPQYbV23dPiNnx0enh3MWCzIwpyayY5koRWJh16XhJi8L6USalH7qFfe2tMrxfJrmYHPY0nOrjJqC-StSZ9ICYFnhxXOy2ywb_5LQLPWFcgkYlxMlSy9NyZ0B4yUVIDBk4UdEDHTQLmYrx6IZl3pwS7vQPfU0Uk9zid55I8K2o1Z9to47-quBxHqIRAXZqUGd3DEuu22cb6MAaHWi21Rz_QeT3hz5G5__w5z7Aw_qX9PkUzAxOWi7EXmz_Q0SAjnJNH65wT4gk1UCSHtEXvS8u90cACdYzU---u9l7ZEH2MLr7oTvk91uvfGvAad19iAcxANyb_bx8_zkJ2Q2Psg |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJwEviG8KA4zEAzxYdWK7SR-raVPH1r7QSXuzbMeBoCWtmhRpfxP_JHeJ04EYGuKxjU92fJe739n3Qch7qaLMiHTM8ogLJqVP8H43ZggVvMmtTdti1fPFeHYuP12oiz1y2OfCYFhl0P2dTm-1dfhnFHZztC6K0We81AP_SkWJaIH0HbKP1anUgOxPT05ni-tID9nW28XxDAn6DLo2zAteADYIY7yStuZp6A5zg4X6GwJtLdHxQ_IgQEg67Vb5iOz56jG5Ow-X5E_Ijym6qkVF122ona8pfPEdOHTUIZc3FM_raVF9N3hYRk2V0bL40gkDtVd003WoB7NGASBSv8bMjUsQVdasWIkJS-7rVQmLaNDUtVFf9MPRfPmRhr4_1IIEULNtVg7TC9sZsMp496v0mG9c1GX9lJwfHy0PZyz0ZGBOjWXDEpGLyMLGS8NNmmfSiTjK_cQr7m1ulePpJE7B7bC551YZNQEPWMTOxBkgs8yLZ2RQrSr_gtAk9plyEfiXYyVzL03OnQH_JRagM2Tmh0T0fNAuFCzHvhmXuo9M-6Y77mnknuYSA_SGhO2o1l3BjlvGq57Fuk9GBfWpwaLcQpfcROfroANqHek61lz_Iae_Uv4m6v8w50Evg_p6mnQCXiYHgzck73aPQUmgJJnKr7Y4BtSyigBsD8nzTnZ3mwP4BBv6yZf_vay35N5sOT_TZyeL01fkPj7B0--IH5BBs9n61wDbGvsmfJY_ASfFQXk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Asporin+promotes+pancreatic+cancer+cell+invasion+and+migration+by+regulating+the+epithelial-to-mesenchymal+transition+%28EMT%29+through+both+autocrine+and+paracrine+mechanisms&rft.jtitle=Cancer+letters&rft.au=Wang%2C+Lili&rft.au=Wu%2C+Huanwen&rft.au=Wang%2C+Li&rft.au=Zhang%2C+Hui&rft.date=2017-07-10&rft.eissn=1872-7980&rft.volume=398&rft.spage=24&rft_id=info:doi/10.1016%2Fj.canlet.2017.04.001&rft_id=info%3Apmid%2F28400334&rft.externalDocID=28400334 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3835&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3835&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3835&client=summon |